Latest Market Reaction News

Kaili Resources has addressed a sharp spike in its share price and trading volume, attributing the market interest to its recent approval for rare earth element drilling in South Australia, while confirming no undisclosed material information.

Resolution Minerals has explained its decision to disclose an unsolicited $225 million offer from Snow Lake Resources for its Horse Heaven Project, despite the offer being non-binding and Snow Lake’s market cap being significantly lower. The company also detailed its recent advisor change amid NASDAQ listing plans.

Aurizon Holdings Limited has announced a fully franked ordinary dividend of AUD 0.065 per share for the six months ending June 2025, payable in September.

The A2 Milk Company has announced a fully franked ordinary dividend of NZD 0.115 per share for the six months ending June 2025, payable in October with flexible currency options for shareholders.

Elanor Investors Group has firmly rejected an unsolicited takeover offer from Lederer Group for its Commercial Property Fund, while progressing a strategic $125 million investment with Rockworth Capital Partners and continuing asset sales to stabilise its balance sheet.

ARC Funds Limited has withdrawn its scrip offer for the remaining shares in The Term Deposit Shop Pty Ltd after securing acceptances for just over 10% of the target shares, raising its ownership to nearly three-quarters of the company.

The Federal Court of Australia has approved Ideagen’s acquisition of Envirosuite via a scheme of arrangement, setting the stage for a $0.09 per share cash payout to shareholders.

Greatland Resources has downgraded its FY26 gold production target and significantly increased capital expenditure forecasts for its Telfer Project, prompting a sharp share price reaction and detailed ASX disclosure.

Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.

Boss Energy has acknowledged significant upward revisions to operating and capital costs at its Honeymoon Uranium Project, alongside challenges in achieving production targets, prompting an independent review.

Macarthur Minerals has successfully raised nearly $2 million through a rights issue, with Gold Valley Yilgarn Pty Ltd underwriting the shortfall and set to become a substantial shareholder pending approval.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.